Document And Entity Information
Document And Entity Information - shares | 3 Months Ended | |
Mar. 31, 2019 | May 15, 2019 | |
Document Information [Line Items] | ||
Entity Registrant Name | CurAegis Technologies, Inc. | |
Entity Central Index Key | 0001063197 | |
Trading Symbol | crgs | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Non-accelerated Filer | |
Entity Current Reporting Status | Yes | |
Entity Emerging Growth Company | false | |
Entity Small Business | true | |
Entity Common Stock, Shares Outstanding (in shares) | 50,434,901 | |
Document Type | 10-Q | |
Document Period End Date | Mar. 31, 2019 | |
Document Fiscal Year Focus | 2019 | |
Document Fiscal Period Focus | Q1 | |
Amendment Flag | false |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) | Mar. 31, 2019 | Dec. 31, 2018 |
Current Assets: | ||
Cash | $ 51,000 | $ 53,000 |
Inventory (net) | ||
Prepaid expenses and other current assets | 13,000 | 25,000 |
Total current assets | 64,000 | 78,000 |
Right to use building asset (net) | 230,000 | |
Property and equipment (net) | 55,000 | 62,000 |
Software (net) | 6,000 | 10,000 |
Total non-current assets | 291,000 | 72,000 |
Total Assets | 355,000 | 150,000 |
Current Liabilities: | ||
Liability for inventory held at vendor | 1,462,000 | 1,462,000 |
Accounts payable | 535,000 | 323,000 |
Accrued interest | 219,000 | 166,000 |
Promissory notes payable | 125,000 | |
Current right-to-use obligation | 109,000 | |
Other current liabilities | 64,000 | 40,000 |
Accrued wages and benefits | 61,000 | 35,000 |
Total current liabilities | 2,575,000 | 2,026,000 |
Non-current right-to-use obligation | 122,000 | |
Senior convertible notes (net) | 7,155,000 | 6,603,000 |
Total Liabilities | 9,852,000 | 8,629,000 |
Commitments and other matters | ||
Stockholders' Deficiency: | ||
Common stock, $.01 par value, 400,000,000 shares authorized; shares issued and outstanding at March 31, 2019 and December 31, 2018: 50,400,545 and 50,364,549, respectively | 504,000 | 504,000 |
Additional paid-in capital | 77,855,000 | 77,725,000 |
Accumulated deficit | (88,297,000) | (87,149,000) |
Total Stockholders' Deficiency | (9,497,000) | (8,479,000) |
Total Liabilities and Stockholders' Deficiency | 355,000 | 150,000 |
Preferred Class C [Member] | ||
Stockholders' Deficiency: | ||
Preferred stock, value | 157,000 | 157,000 |
Series C2 Preferred Stock [Member] | ||
Stockholders' Deficiency: | ||
Preferred stock, value | 245,000 | 245,000 |
Series C3 Preferred Stock [Member] | ||
Stockholders' Deficiency: | ||
Preferred stock, value | 33,000 | 33,000 |
Preferred Class A [Member] | ||
Stockholders' Deficiency: | ||
Preferred stock, value | 5,000 | 5,000 |
Preferred Class B [Member] | ||
Stockholders' Deficiency: | ||
Preferred stock, value | $ 1,000 | $ 1,000 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares | Mar. 31, 2019 | Dec. 31, 2018 |
Preferred stock, shares authorized (in shares) | 100,000,000 | 100,000,000 |
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized (in shares) | 400,000,000 | 400,000,000 |
Common stock, shares issued (in shares) | 50,400,545 | 50,364,549 |
Common stock, shares outstanding (in shares) | 50,400,545 | 50,364,549 |
Preferred Class C [Member] | ||
Preferred stock, cumulative dividend per share (in dollars per share) | $ 0 | $ 0 |
Preferred stock, shares issued (in shares) | 15,687,500 | 15,687,500 |
Preferred stock, shares outstanding (in shares) | 15,687,500 | 15,687,500 |
Series C2 Preferred Stock [Member] | ||
Preferred stock, cumulative dividend per share (in dollars per share) | $ 0 | $ 0 |
Preferred stock, shares issued (in shares) | 24,500,000 | 24,500,000 |
Preferred stock, shares outstanding (in shares) | 24,500,000 | 24,500,000 |
Series C3 Preferred Stock [Member] | ||
Preferred stock, cumulative dividend per share (in dollars per share) | $ 0 | $ 0 |
Preferred stock, shares issued (in shares) | 3,268,000 | 3,268,000 |
Preferred stock, shares outstanding (in shares) | 3,268,000 | 3,268,000 |
Preferred Class A [Member] | ||
Preferred stock, cumulative dividend per share (in dollars per share) | $ 0.40 | $ 0.40 |
Preferred stock, shares issued (in shares) | 468,221 | 468,221 |
Preferred stock, shares outstanding (in shares) | 468,221 | 468,221 |
Preferred Class B [Member] | ||
Preferred stock, cumulative dividend per share (in dollars per share) | $ 0.50 | $ 0.50 |
Preferred stock, shares issued (in shares) | 67,500 | 67,500 |
Preferred stock, shares outstanding (in shares) | 67,500 | 67,500 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | |
Revenue and Cost of revenue: | ||
CURA revenue | $ 7,000 | $ 8,000 |
Cost of revenue | 6,000 | 37,000 |
Margin (loss) on revenue | 1,000 | (29,000) |
Costs and expenses: | ||
Engineering and development | 331,000 | 405,000 |
General and administrative | 544,000 | 625,000 |
Total costs and expenses | 875,000 | 1,030,000 |
Loss from operations | (874,000) | (1,059,000) |
Non-operating expense: | ||
Interest expense | (274,000) | (237,000) |
Other income | 1,000 | |
(274,000) | (236,000) | |
Loss before income taxes | (1,148,000) | (1,295,000) |
Income taxes | ||
Net loss | (1,148,000) | (1,295,000) |
Preferred stock dividends | 54,000 | 54,000 |
Net loss attributable to common stockholders | $ (1,202,000) | $ (1,349,000) |
Net loss per share attributable to common stockholders | ||
Basic and Diluted (in dollars per share) | $ (0.02) | $ (0.03) |
Weighted average number of shares of common stock | ||
Basic and Diluted (in shares) | 50,401,000 | 49,031,000 |
Condensed Consolidated Statem_2
Condensed Consolidated Statement of Changes in Stockholders' (Deficit) (Unaudited) - USD ($) | Preferred Stock [Member]Series C Preferred Stock [Member] | Preferred Stock [Member]Series C2 Preferred Stock [Member] | Preferred Stock [Member]Series C3 Preferred Stock [Member] | Preferred Stock [Member]Preferred Class A [Member] | Preferred Stock [Member]Preferred Class B [Member] | Common Stock [Member] | Additional Paid-in Capital [Member] | Retained Earnings [Member] | Series C3 Preferred Stock [Member] | Total |
Balance (in shares) at Dec. 31, 2017 | 15,937,500 | 25,000,000 | 3,388,000 | 468,221 | 67,500 | 48,979,546 | ||||
Balance at Dec. 31, 2017 | $ 159,000 | $ 250,000 | $ 34,000 | $ 5,000 | $ 1,000 | $ 490,000 | $ 76,494,000 | $ (80,841,000) | $ (3,408,000) | |
Conversion Preferred C-3 to common stock (in shares) | (80,000) | 80,000 | 80,000 | |||||||
Conversion Preferred C-3 to common stock | $ (1,000) | $ 1,000 | ||||||||
Stock-based compensation | 2,000 | 2,000 | ||||||||
Issuance of warrants with convertible notes | 208,000 | 208,000 | ||||||||
Beneficial conversion feature on convertible note | 11,000 | 11,000 | ||||||||
Net Loss | (1,295,000) | (1,295,000) | ||||||||
Balance (in shares) at Mar. 31, 2018 | 15,937,500 | 25,000,000 | 3,308,000 | 468,221 | 67,500 | 49,059,546 | ||||
Balance at Mar. 31, 2018 | $ 159,000 | $ 250,000 | $ 33,000 | $ 5,000 | $ 1,000 | $ 491,000 | 76,715,000 | (82,136,000) | (4,482,000) | |
Balance (in shares) at Dec. 31, 2018 | 15,687,500 | 24,500,000 | 3,268,000 | 468,221 | 67,500 | 50,364,549 | ||||
Balance at Dec. 31, 2018 | $ 157,000 | $ 245,000 | $ 33,000 | $ 5,000 | $ 1,000 | $ 504,000 | 77,725,000 | (87,149,000) | (8,479,000) | |
Stock-based compensation | 59,000 | 59,000 | ||||||||
Issuance of warrants with convertible notes | 63,000 | 63,000 | ||||||||
Net Loss | (1,148,000) | (1,148,000) | ||||||||
Balance (in shares) at Mar. 31, 2019 | 15,687,500 | 24,500,000 | 3,268,000 | 468,221 | 67,500 | 50,400,545 | ||||
Balance at Mar. 31, 2019 | $ 157,000 | $ 245,000 | $ 33,000 | $ 5,000 | $ 1,000 | $ 504,000 | 77,855,000 | (88,297,000) | (9,497,000) | |
Common Shares issued for interest (in shares) | 35,996 | |||||||||
Common Shares issued for interest | $ 8,000 | $ 8,000 |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) | 3 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | |
Cash flows used in operating activities: | ||
Net loss | $ (1,148,000) | $ (1,295,000) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Amortization of debt discount reported as interest | 165,000 | 139,000 |
Depreciation and amortization | 11,000 | 44,000 |
Stock-based compensation | 59,000 | 2,000 |
Interest paid in common stock | 9,000 | |
Changes in working capital items: | ||
Accounts receivable | (6,000) | |
Inventory | 3,000 | |
Prepaid expenses and other current assets | 12,000 | |
Accounts payable and other current liabilities | 315,000 | (89,000) |
Net cash used in operating activities | (577,000) | (1,202,000) |
Cash flows from financing activities: | ||
Proceeds from issuance of senior convertible note (net) | 450,000 | 1,200,000 |
Proceeds from issuance of unsecured subordinated notes | 125,000 | |
Net cash provided by financing activities | 575,000 | 1,200,000 |
Net decrease in cash | (2,000) | (2,000) |
Cash at beginning of period | 53,000 | 194,000 |
Cash at end of period | 51,000 | 192,000 |
Supplemental Disclosures: | ||
Right to use asset | 230,000 | |
Cash used for payment of interest expense | 47,000 | 80,000 |
Debt discount related to warrants and beneficial conversion feature | 63,000 | 219,000 |
Common stock issued in payment of interest expense | $ 8,000 |
Note 1 - The Company and Basis
Note 1 - The Company and Basis of Presentation | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] | NOTE 1 CurAegis Technologies, Inc. (“CurAegis”, “the Company”) was incorporated as a New York business corporation in September 1996 2016 two The Company develops and markets advanced technologies in the areas of safety, wellness and power. The Company is focused on the commercialization of a wellness and safety system (the CURA System) and a uniquely designed hydraulic pump that will be smaller, lighter, less expensive and more efficient than current technology. The Company has not The Company has created the CURA System to market products that reduce fatigue risk in the workplace and help individuals manage their sleep and improve alertness. The CURA System consists of the following capabilities: ● real-time alertness utilizing the CURA app, ● the Group Wellness Index and ● the Z-Coach wellness program. The Aegis hydraulic pump technology has been designed to bring to the marketplace a unique concept in hydraulic pumps and motors that will be: ● smaller, lighter and less expensive than conventional pumps and motors, ● more efficient, ● as reliable, ● unique in its ability to scale larger, allowing more powerful pumps and motors. It is important to note, regarding both the CURA and Aegis products, that the cycle time from the initiation of the sales process to revenue realization can be highly variable especially as a start-up entity. In addition to the activities to be undertaken to implement our plan of operations, we may Current Cash Outlook and Management Plans As of March 31, 2019, $51,000, $2,511,000, $9,497,000 $88,297,000. three March 31, 2019 $575,000 Management estimates that the 2019 $3 $3.5 fourth 2018. March 31, 2019, not Since inception, we have financed our operations by the sale of our securities and debt financings. We need to raise additional funds to meet our working capital needs, to fund expansion of our business, to complete development, testing and marketing of our products, or to make strategic acquisitions or investments. No may not The Company’s ability to fund its current and future commitments from its available cash depends on a number of factors. These factors include the Company’s ability to (i) launch and generate sales from the CURA division; (ii) generate revenue from the monetization of our hydraulic technologies or; (iii) decrease engineering and development and administrative expenses. If these and other factors are not no |
Note 2 - Summary of Significant
Note 2 - Summary of Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Significant Accounting Policies [Text Block] | NOTE 2 Basis of Presentation: 10 8 03 X not not December 31, 2018 2018 10 Consolidation: 56% March 31, 2019, Use of Estimates: Reclassifications: may Cash: may $5,000. Inventory March 31, 2019 December 31, 2018 $1,747,000 Right to use building asset The FASB issued ASU No. 2016 02, The standard became effective for the Company January 1, 2019. not not no Software, Property and Equipment: Software (in years) 3 Office equipment (in years) 5 - 7 Leasehold improvements lesser of useful life or lease term Depreciation and amortization are computed using the straight-line method. Betterments, renewals and significant repairs that extend the life of the assets are capitalized. Other repairs and maintenance costs are expensed when incurred. When disposed, the cost and accumulated depreciation applicable to assets retired are removed from the accounts and the gain or loss on disposition is recognized in other income (expense). Depreciation and software amortization expense for the three March 31, 2019 2018 $11,000 $44,000, Whenever events or circumstances indicate, our long-lived assets including any intangible assets with finite useful lives are tested for impairment by using the estimated future cash flows directly associated with, and that are expected to arise as a direct result of, the use of the assets. If the carrying amount exceeds the estimated undiscounted cash flows, impairment may Fair Value of Financial Instruments: , one three Level 1: Level 2: Level 3: not The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 3 March 31, 2019 December 31, 2018. $5,454,000 March 31, 2019 March 31, 2019. Revenue Recognition and Deferred Revenue: January 1, 2018, 606, no 606. not not two The Company's net revenue is derived primarily from domestic customers. For the three March 31, 2019 $7,000 no 89% three March 31, 2019. 30 CURA revenue is recognized (a) upon receipt of payment at the point of sale of the CURA app, (b) upon the delivery of myCadian products and (c) upon the company’s satisfaction of all performance obligations as described in customer agreements. The Z-Coach Program provides fatigue training over an annual subscription period of twelve 30 Engineering and Development and Patents: three March 31, 2019 2018 $10,000 $31,000, Stock-based Compensation: 718 10 may 718 10. No During 2018, 2018 07, 718 20 January 1, 2018 $10,000 Income Taxes: not not We account for uncertain tax positions using a more-likely-than- not not not March 31, 2019, December 31, 2018, no Loss per Common Share: 260 10 March 31, 2019 2018, 96,927,383 84,560,427 625,000 March 31, 2019 2018 not |
Note 3 - Inventory and Related
Note 3 - Inventory and Related Vendor Liability | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Inventory Disclosure [Text Block] | NOTE 3 The Company had the following inventory held at our manufacturing vendor and on hand as of March 31, 2019 December 31, 2018: March 31, 2019 December 31, 2018 Raw materials $ 1,678,000 $ 1,678,000 Finished goods 69,000 69,000 1,747,000 1,747,000 Less: Reserve for quality (1,747,000 ) (1,747,000 ) Inventory (net) $ - $ - Liability for inventory held at vendor $ 1,462,000 $ 1,462,000 During 2017, third $1,678,000 $1,462,000 During the 2018, $1,741,000 |
Note 4 - Senior Convertible Not
Note 4 - Senior Convertible Notes and Warrants | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Debt Disclosure [Text Block] | NOTE 4 At March 31, 2019, $9,610,000 $2,455,000, $7,155,000. December 31, 2018, $9,160,000 $2,557,000 $6,603,000. none twelve December 31, 2019 2020; $2,990,000 twelve December 31, 2021; $2,775,500 twelve December 31, 2022; $3,395,000 twelve December 31, 2023 $450,000 Included in the face value of convertible notes outstanding at March 31, 2019 December 31, 2018, $2,252,500 six $1,170,000 Total JULY 2018 Convertible Notes 2018 Convertible Notes 2017 6% Convertible Notes 2016 6% Convertible Notes Face value December 31, 2018 $ 9,160,000 $ 1,175,000 $ 625,000 $ 4,370,000 $ 2,990,000 Notes issued in current period 450,000 450,000 - - - Face value March 31, 2019 $ 9,610,000 $ 1,625,000 $ 625,000 $ 4,370,000 $ 2,990,000 Debt discount December 31, 2018 $ (2,557,000 ) $ (360,000 ) $ (231,000 ) $ (456,000 ) $ (1,510,000 ) Debt discount on notes issued in current period (63,000 ) (63,000 ) - - - Amortization of discount reported as interest 165,000 13,000 11,000 15,000 126,000 Debt discount March 31, 2019 $ (2,455,000 ) $ (410,000 ) $ (220,000 ) $ (441,000 ) $ (1,384,000 ) Senior Convertible Notes (net) $ 7,155,000 $ 1,215,000 $ 405,000 $ 3,929,000 $ 1,606,000 JULY 2018 In July 2018, $2.5 “JULY 2018 July 24, 2018 “JULY 2018 JULY 2018 five The conversion rate of the notes was fixed at $0.25 July 24, 2018. 10% 25% $0.25 ten 4 2 1933 506 501 During the three March 31, 2019, $450,000 $63,000 three March 31, 2019 March 31, 2018, $13,000 $0 2018 In May 2018, $1 “2018 May 8, 2018 “2018 2018 five July 19, 2018, 2018 $625,000 460,000 The conversion rate of the notes was fixed at $0.25 May 8, 2018. 10% 25% $0.25 ten 4 2 1933 506 501 During the three March 31, 2019 March 31, 2018, $11,000 $0, 2017 The board of directors authorized the issuance of up to $5 6% “2017 May 31, 2017 “2017 2017 $4,420,000 2,307,207 2017 five 6%. 10% 25% The 2017 4 2 506 501 During the three March 31, 2019 $80,000 $15,000 three March 31, 2018, $74,000 $21,000 2016 During 2016, $3 6% “2016 August 25, 2016 “2016 2016 five August 2021 December 2021 6%. first The conversion rate of the notes was fixed at $0.25 August 25, 2016. 10% $0.25 ten 4 2 1934, 506 501 1933. During the period ending March 31, 2019, $169,000 $126,000. three March 31, 2018 $163,000 $118,000. |
Note 5 - Unsecured Subordinated
Note 5 - Unsecured Subordinated Promissory Notes | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Short-term Debt [Text Block] | NOTE 5 – UNSECURED SUBORDINATED PROMISSORY NOTES During the first 2018, $125,000 6% ninety |
Note 6 - Right-to-use Building
Note 6 - Right-to-use Building Asset | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Lessee, Operating Leases [Text Block] | NOTE 6 – RIGHT-TO-USE BUILDING ASSET The FASB issued ASU No. 2016 02, January 1, 2019. not no The Company measured the present value of future lease costs at $257,000 January 1, 2019. 6% not one May 2021. Operating lease costs for the first 2019 $30,000 2019: $85,000 nine 2019; $114,000 2020 $57,000 2021. $256,000 $18,000. |
Note 7 - Software
Note 7 - Software | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Research, Development, and Computer Software Disclosure [Text Block] | NOTE 7 - SOFTWARE The Company investments in software for the CURA system are amortized over an estimated useful life of 3 three March 31, 2019 2018 $4,000 $31,000, March 31, 2019 2018 $6,000 $71,000, $6,000 2019. |
Note 8 - Property and Equipment
Note 8 - Property and Equipment | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Property, Plant and Equipment Disclosure [Text Block] | NOTE 8 - PROPERTY AND EQUIPMENT At March 31, 2019 December 31, 2018 March 31, 2019 December 31, 2018 Office equipment $ 249,000 $ 249,000 Shop equipment 182,000 182,000 Leasehold improvements 253,000 253,000 684,000 684,000 Less accumulated depreciation (629,000 ) (622,000 ) Net property and equipment $ 55,000 $ 62,000 Depreciation expense for the three March 31, 2019 2018 $7,000 $13,000 |
Note 9 - Business Segments
Note 9 - Business Segments | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Segment Reporting Disclosure [Text Block] | NOTE 9 - BUSINESS SEGMENTS The Company has two Segment information for the three March 31, 2019 for the Company’s business segments follows: CURA Aegis Corporate Total Revenue $ 7,000 $ - $ - $ 7,000 Earnings on revenue 1,000 - - 1,000 Total costs and expenses 339,000 169,000 367,000 875,000 Loss from operations 338,000 169,000 367,000 874,000 Interest and other expense - - 274,000 274,000 Net loss $ 338,000 $ 169,000 $ 641,000 $ 1,148,000 Stock based compensation $ 8,000 $ 8,000 $ 43,000 $ 59,000 Depreciation and amortization $ 6,000 $ 5,000 $ - $ 11,000 Assets at March 31, 2019 $ 9,000 $ 50,000 $ 296,000 $ 355,000 Segment information for the three March 31, 2018 for the Company’s business segments follows: CURA Aegis Corporate Total Revenue $ 8,000 $ - $ - $ 8,000 Loss on revenue 29,000 - - 29,000 Total costs and expenses 523,000 131,000 376,000 1,030,000 Loss from operations 552,000 131,000 376,000 1,059,000 Interest and other expense - - 236,000 236,000 Net loss $ 552,000 $ 131,000 $ 612,000 $ 1,295,000 Stock based compensation $ (16,000 ) $ 2,000 $ 16,000 $ 2,000 Depreciation and amortization $ 37,000 $ 5,000 $ 2,000 $ 44,000 Assets at March 31, 2018 $ 1,860,000 $ 70,000 $ 227,000 $ 2,157,000 |
Note 10 - Preferred and Common
Note 10 - Preferred and Common Stock | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Stockholders' Equity Note Disclosure [Text Block] | NOTE 10 - PREFERRED and COMMON STOCK Common Stock We have authorized 400,000,000 $0.01 During the three March 31, 2019 35,996 $0.25 2016 2017 three March 31, 2018 80,000 3 Preferred Stock Our certificate of incorporation permits the Company to issue up to 100,000,000 $.01 Class A Preferred Stock At March 31, 2019 December 31, 2018 468,221 8,709 no 459,512 $2,576,000 March 31, 2019 $2,530,000 December 31, 2018. In the event of a liquidation, dissolution and winding up of the Company, and subject to the liquidation rights and privileges of our Class C Preferred stockholders, Class A Preferred stockholders have a liquidation preference with respect to all accumulated and unsettled dividends. The value of the Class A Preferred stockholders’ liquidation preference was $2,576,000 $2,530,000 March 31, 2019 December 31, 2018, 1 $4.00 Class B Preferred Stock At March 31, 2019 December 31, 2018, 67,500 $462,000 March 31, 2019 $454,000 December 31, 2018. In the event of liquidation, dissolution and winding up of the Company, and subject to the liquidation rights and privileges of our Class C Preferred stockholders and our Class A Preferred stockholders, Class B Preferred stockholders have a liquidation preference with respect to all accumulated and unsettled dividends. The value of the Class B Preferred stockholders’ liquidation preference was $462,000 $454,000 March 31, 2019 December 31, 2018, 1 $5.00 Series C Preferred Stock At March 31, 2019 December 31, 2018, 15,687,500 $6,275,000 March 31, 2019 December 31, 2018. The Series C Preferred shares have a liquidation preference at their stated value per share of $0.40 The Series C Preferred shares have no no Series C- 2 Preferred Stock At March 31, 2019 December 31, 2018, 24,500,000 2 2 $4,900,000 March 31, 2019 December 31, 2018. The Series C- 2 not no 2 may not, two 2 2 2 2 2 2 2 2 not Series C- 3 Preferred Stock At March 31, 2019 December 31, 2018, 3,268,000 3 6,042,000 3 2016. |
Note 11 - Stock Options
Note 11 - Stock Options | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Share-based Payment Arrangement [Text Block] | NOTE 1 1 - STOCK OPTIONS 2016 Stock Option Plan 2016 “2016 3,000,000 may 2016 March 31, 2019, 1,220,000 2016 1,780,000 2011 Stock Option Plan 2011 “2011 3,000,000 may 2011 March 31, 2019, 91,500 2011 Under the 2016 2011 may may may not 10% may not 110% ten 10% may not five During the three March 31, 2019, no three March 31, 2018, 150,000 Non-Plan Options Summary three March 31, 2019 2018, $59,000 $2,000, March 31, 2019, $238,000 1.1 The weighted average grant date fair value of stock options granted during the three March 31, 2019 2018 zero $0.33, three March 31, 2019 2018 $4,000 $22,000, The fair value of each option granted was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions: 2019 2018 Expected term (years) - 6.3 Expected forfeiture rate - 0% Risk-free rate - 2.6% Volatility - 130% Dividend yield - 0.0% The average risk-free interest rate is based on the U.S. treasury security rate in effect as of the grant date. We determined expected volatility using the historical closing stock price. The expected life was generally determined using the simplified method as we do not The following summarizes the activity of all of our outstanding stock options for the quarter ended March 31, 2019: Weighted Average Average Remaining Aggregate Exercise Contractual Intrinsic Shares Price Term (years) Value Outstanding at January 1, 2019 11,028,500 $ 0.49 3.8 $ 94,000 Granted - - Exercised - - Canceled or expired - - Outstanding at March 31, 2019 11,028,500 $ 0.49 3.5 $ - Exercisable at March 31, 2019 7,068,500 $ 0.58 2.7 $ - During the quarter ended March 31, 2019, no March 31, 2018, no March 31, 2018, 191,875 March 31, 2019, 2,908,500 2011 2,048,500 91,500 2011 March 31, 2019, 1,220,000 2016 270,000 1,780,000 2016 As of March 31, 2019, $.22 $1.58 |
Note 12 - Warrants
Note 12 - Warrants | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Stockholders Equity Note Warrants Or Rights [Text Block] | NOTE 1 2 - WARRANTS The following summarizes the activity of our outstanding warrants for the three March 31, 2019: Weighted Weighted Average Average Remaining Aggregate Exercise Contractual Intrinsic Shares Price Term Value Outstanding at January 1, 2019 7,381,707 $ 0.46 (A) 7.0 (B) $ 39,000 Granted 330,000 0.25 Exercised - - Canceled or expired - - Outstanding at March 31, 2019 7,711,707 $ 0.45 (A) 6.9 (B) $ 31,000 Exercisable at March 31, 2019 7,070,786 $ 0.44 7.0 (C) $ 30,000 (A) The weighted average exercise price for warrants outstanding as of March 31, 2019 2018 1,750,000 no (B) The weighted average remaining contractual term for warrants outstanding as of March 31, 2019 2018 743,500 no (C) The weighted average remaining contractual term for warrants exercisable as of March 31, 2019, 2018 118,500 no |
Note 13 - Related Party Transac
Note 13 - Related Party Transactions | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Related Party Transactions Disclosure [Text Block] | NOTE 1 3 - RELATED PARTY TRANSACTIONS As of March 31, 2019, December 31, 2018, $2,252,500 six 7,888,378 March 31, 2019 December 31, 2018. 1,239,285 March 31, 2019 December 31, 2018. During the first 2019, $125,000 ninety 6% |
Note 14 - Subsequent Events
Note 14 - Subsequent Events | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Subsequent Events [Text Block] | NOTE 1 4 - SUBSEQUENT EVENTS JULY 2018 Subsequent to March 31, 2019, $50,000 JULY 2018 20,000 Unsecured S ubordinated P romissory N otes with Related Party On each of April 4, 2019 May 1, 2019, $100,000 first July 3, 2019, second July 30, 2019. 6% Common shares Issued in Payment of Interest Expense Subsequent to March 31, 2019, 34,356 $8,589 |
Significant Accounting Policies
Significant Accounting Policies (Policies) | 3 Months Ended |
Mar. 31, 2019 | |
Accounting Policies [Abstract] | |
Consolidation, Policy [Policy Text Block] | Consolidation: 56% March 31, 2019, |
Use of Estimates, Policy [Policy Text Block] | Use of Estimates: |
Reclassification, Policy [Policy Text Block] | Reclassifications: may |
Cash and Cash Equivalents, Policy [Policy Text Block] | Cash: may $5,000. |
Inventory, Policy [Policy Text Block] | Inventory March 31, 2019 December 31, 2018 $1,747,000 |
Lessee, Leases [Policy Text Block] | Right to use building asset The FASB issued ASU No. 2016 02, The standard became effective for the Company January 1, 2019. not not no |
Software Property And Equipment [Policy Text Block] | Software, Property and Equipment: Software (in years) 3 Office equipment (in years) 5 - 7 Leasehold improvements lesser of useful life or lease term Depreciation and amortization are computed using the straight-line method. Betterments, renewals and significant repairs that extend the life of the assets are capitalized. Other repairs and maintenance costs are expensed when incurred. When disposed, the cost and accumulated depreciation applicable to assets retired are removed from the accounts and the gain or loss on disposition is recognized in other income (expense). Depreciation and software amortization expense for the three March 31, 2019 2018 $11,000 $44,000, Whenever events or circumstances indicate, our long-lived assets including any intangible assets with finite useful lives are tested for impairment by using the estimated future cash flows directly associated with, and that are expected to arise as a direct result of, the use of the assets. If the carrying amount exceeds the estimated undiscounted cash flows, impairment may |
Fair Value Measurement, Policy [Policy Text Block] | Fair Value of Financial Instruments: , one three Level 1: Level 2: Level 3: not The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 3 March 31, 2019 December 31, 2018. $5,454,000 March 31, 2019 March 31, 2019. |
Revenue [Policy Text Block] | Revenue Recognition and Deferred Revenue: January 1, 2018, 606, no 606. not not two The Company's net revenue is derived primarily from domestic customers. For the three March 31, 2019 $7,000 no 89% three March 31, 2019. 30 CURA revenue is recognized (a) upon receipt of payment at the point of sale of the CURA app, (b) upon the delivery of myCadian products and (c) upon the company’s satisfaction of all performance obligations as described in customer agreements. The Z-Coach Program provides fatigue training over an annual subscription period of twelve 30 |
In Process Research and Development, Policy [Policy Text Block] | Engineering and Development and Patents: three March 31, 2019 2018 $10,000 $31,000, |
Share-based Payment Arrangement [Policy Text Block] | Stock-based Compensation: 718 10 may 718 10. No During 2018, 2018 07, 718 20 January 1, 2018 $10,000 |
Income Tax, Policy [Policy Text Block] | Income Taxes: not not We account for uncertain tax positions using a more-likely-than- not not not March 31, 2019, December 31, 2018, no |
Earnings Per Share, Policy [Policy Text Block] | Loss per Common Share: 260 10 March 31, 2019 2018, 96,927,383 84,560,427 625,000 March 31, 2019 2018 not |
Note 2 - Summary of Significa_2
Note 2 - Summary of Significant Accounting Policies (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Notes Tables | |
Software, Property and Equipment Estimated Useful Life [Table Text Block] | Software (in years) 3 Office equipment (in years) 5 - 7 Leasehold improvements lesser of useful life or lease term |
Note 3 - Inventory and Relate_2
Note 3 - Inventory and Related Vendor Liability (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Notes Tables | |
Schedule of Inventory, Current [Table Text Block] | March 31, 2019 December 31, 2018 Raw materials $ 1,678,000 $ 1,678,000 Finished goods 69,000 69,000 1,747,000 1,747,000 Less: Reserve for quality (1,747,000 ) (1,747,000 ) Inventory (net) $ - $ - Liability for inventory held at vendor $ 1,462,000 $ 1,462,000 |
Note 4 - Senior Convertible N_2
Note 4 - Senior Convertible Notes and Warrants (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Notes Tables | |
Convertible Debt [Table Text Block] | Total JULY 2018 Convertible Notes 2018 Convertible Notes 2017 6% Convertible Notes 2016 6% Convertible Notes Face value December 31, 2018 $ 9,160,000 $ 1,175,000 $ 625,000 $ 4,370,000 $ 2,990,000 Notes issued in current period 450,000 450,000 - - - Face value March 31, 2019 $ 9,610,000 $ 1,625,000 $ 625,000 $ 4,370,000 $ 2,990,000 Debt discount December 31, 2018 $ (2,557,000 ) $ (360,000 ) $ (231,000 ) $ (456,000 ) $ (1,510,000 ) Debt discount on notes issued in current period (63,000 ) (63,000 ) - - - Amortization of discount reported as interest 165,000 13,000 11,000 15,000 126,000 Debt discount March 31, 2019 $ (2,455,000 ) $ (410,000 ) $ (220,000 ) $ (441,000 ) $ (1,384,000 ) Senior Convertible Notes (net) $ 7,155,000 $ 1,215,000 $ 405,000 $ 3,929,000 $ 1,606,000 |
Note 8 - Property and Equipme_2
Note 8 - Property and Equipment (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Notes Tables | |
Property, Plant and Equipment [Table Text Block] | March 31, 2019 December 31, 2018 Office equipment $ 249,000 $ 249,000 Shop equipment 182,000 182,000 Leasehold improvements 253,000 253,000 684,000 684,000 Less accumulated depreciation (629,000 ) (622,000 ) Net property and equipment $ 55,000 $ 62,000 |
Note 9 - Business Segments (Tab
Note 9 - Business Segments (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Notes Tables | |
Schedule of Segment Reporting Information, by Segment [Table Text Block] | CURA Aegis Corporate Total Revenue $ 7,000 $ - $ - $ 7,000 Earnings on revenue 1,000 - - 1,000 Total costs and expenses 339,000 169,000 367,000 875,000 Loss from operations 338,000 169,000 367,000 874,000 Interest and other expense - - 274,000 274,000 Net loss $ 338,000 $ 169,000 $ 641,000 $ 1,148,000 Stock based compensation $ 8,000 $ 8,000 $ 43,000 $ 59,000 Depreciation and amortization $ 6,000 $ 5,000 $ - $ 11,000 Assets at March 31, 2019 $ 9,000 $ 50,000 $ 296,000 $ 355,000 CURA Aegis Corporate Total Revenue $ 8,000 $ - $ - $ 8,000 Loss on revenue 29,000 - - 29,000 Total costs and expenses 523,000 131,000 376,000 1,030,000 Loss from operations 552,000 131,000 376,000 1,059,000 Interest and other expense - - 236,000 236,000 Net loss $ 552,000 $ 131,000 $ 612,000 $ 1,295,000 Stock based compensation $ (16,000 ) $ 2,000 $ 16,000 $ 2,000 Depreciation and amortization $ 37,000 $ 5,000 $ 2,000 $ 44,000 Assets at March 31, 2018 $ 1,860,000 $ 70,000 $ 227,000 $ 2,157,000 |
Note 11 - Stock Options (Tables
Note 11 - Stock Options (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Notes Tables | |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] | 2019 2018 Expected term (years) - 6.3 Expected forfeiture rate - 0% Risk-free rate - 2.6% Volatility - 130% Dividend yield - 0.0% |
Share-based Payment Arrangement, Option, Activity [Table Text Block] | Weighted Average Average Remaining Aggregate Exercise Contractual Intrinsic Shares Price Term (years) Value Outstanding at January 1, 2019 11,028,500 $ 0.49 3.8 $ 94,000 Granted - - Exercised - - Canceled or expired - - Outstanding at March 31, 2019 11,028,500 $ 0.49 3.5 $ - Exercisable at March 31, 2019 7,068,500 $ 0.58 2.7 $ - |
Note 12 - Warrants (Tables)
Note 12 - Warrants (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Warrant [Member] | |
Notes Tables | |
Share-based Payment Arrangement, Activity [Table Text Block] | Weighted Weighted Average Average Remaining Aggregate Exercise Contractual Intrinsic Shares Price Term Value Outstanding at January 1, 2019 7,381,707 $ 0.46 (A) 7.0 (B) $ 39,000 Granted 330,000 0.25 Exercised - - Canceled or expired - - Outstanding at March 31, 2019 7,711,707 $ 0.45 (A) 6.9 (B) $ 31,000 Exercisable at March 31, 2019 7,070,786 $ 0.44 7.0 (C) $ 30,000 |
Note 1 - The Company and Basi_2
Note 1 - The Company and Basis of Presentation (Details Textual) | 3 Months Ended | |||
Mar. 31, 2019USD ($) | Dec. 31, 2018USD ($) | Mar. 31, 2018USD ($) | Dec. 31, 2017USD ($) | |
Number of Operating Segments | 2 | |||
Cash and Cash Equivalents, at Carrying Value, Ending Balance | $ 51,000 | $ 53,000 | $ 192,000 | $ 194,000 |
Working Capital | (2,511,000) | |||
Stockholders' Equity Attributable to Parent, Ending Balance | (9,497,000) | (8,479,000) | $ (4,482,000) | $ (3,408,000) |
Retained Earnings (Accumulated Deficit), Ending Balance | (88,297,000) | $ (87,149,000) | ||
Proceeds From Convertible Debt, Gross | 575,000 | |||
Minimum [Member] | ||||
Cash Needed During the Year to Fund Current and Future Commitments | 3,000,000 | |||
Maximum [Member] | ||||
Cash Needed During the Year to Fund Current and Future Commitments | $ 3,500,000 |
Note 2 - Summary of Significa_3
Note 2 - Summary of Significant Accounting Policies (Details Textual) - USD ($) | Jan. 01, 2018 | Mar. 31, 2019 | Mar. 31, 2018 | Dec. 31, 2018 |
Inventory Valuation Reserves, Ending Balance | $ 1,747,000 | $ 1,747,000 | ||
Depreciation, Depletion and Amortization, Total | 11,000 | $ 44,000 | ||
Revenue from Contract with Customer, Including Assessed Tax | 7,000 | 8,000 | ||
Research and Development Expense, Total | 331,000 | 405,000 | ||
Excess Tax Benefit from Share-based Compensation, Operating Activities | 0 | |||
Share-based Payment Arrangement, Expense | 59,000 | $ 2,000 | ||
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total | $ 0 | $ 0 | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 96,927,383 | 84,560,427 | ||
Warrant [Member] | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 625,000 | 625,000 | ||
Accounting Standards Update 2018-07 [Member] | Share-based Payment Arrangement, Option [Member] | ||||
Share-based Payment Arrangement, Expense | $ (10,000) | |||
Patents [Member] | General and Administrative Expense [Member] | ||||
Research and Development Expense, Total | $ 10,000 | $ 31,000 | ||
Z-Coach Aviation Wellness Program Annual Subscription [Member] | ||||
Deferred Revenue Arrangement, Subscription Period | 1 year | |||
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer One [Member] | ||||
Concentration Risk, Percentage | 89.00% | |||
Transferred over Time [Member] | ||||
Revenue from Contract with Customer, Including Assessed Tax | $ 7,000 | |||
Transferred at Point in Time [Member] | ||||
Revenue from Contract with Customer, Including Assessed Tax | 0 | |||
Senior Convertible Promissory Notes [Member] | ||||
Long-term Debt, Fair Value | 5,454,000 | |||
Commercial Paper [Member] | Collateral Pledged [Member] | ||||
Debt Instrument, Collateral Amount | $ 5,000 | |||
Subsidiaries [Member] | ||||
Equity Method Investment, Ownership Percentage | 56.00% |
Note 2 - Summary of Significa_4
Note 2 - Summary of Significant Accounting Policies - Property, and Equipment, Estimated Useful Lives (Details) | 3 Months Ended |
Mar. 31, 2019 | |
Office Equipment [Member] | Minimum [Member] | |
Property plant and equipment, useful lives (Year) | 5 years |
Office Equipment [Member] | Maximum [Member] | |
Property plant and equipment, useful lives (Year) | 7 years |
Leasehold Improvements [Member] | |
Property plant and equipment, useful lives | lesser of useful life or lease term |
Computer Software, Intangible Asset [Member] | |
Property plant and equipment, useful lives (Year) | 3 years |
Note 3 - Inventory and Relate_3
Note 3 - Inventory and Related Vendor Liability (Details Textual) - USD ($) | 12 Months Ended | |
Dec. 31, 2018 | Mar. 31, 2019 | |
Inventory, Raw Materials, Gross, Total | $ 1,678,000 | $ 1,678,000 |
Liability for Inventory Held at Vendor | 1,462,000 | $ 1,462,000 |
Inventory Write-down | $ 1,741,000 |
Note 3 - Inventory and Relate_4
Note 3 - Inventory and Related Vendor Liability - Inventory (Details) - USD ($) | Mar. 31, 2019 | Dec. 31, 2018 |
Raw materials | $ 1,678,000 | $ 1,678,000 |
Finished goods | 69,000 | 69,000 |
1,747,000 | 1,747,000 | |
Less: Reserve for quality | (1,747,000) | (1,747,000) |
Inventory (net) | ||
Liability for inventory held at vendor | $ 1,462,000 | $ 1,462,000 |
Note 4 - Senior Convertible N_3
Note 4 - Senior Convertible Notes and Warrants (Details Textual) - USD ($) | Jul. 24, 2018 | May 08, 2018 | Aug. 25, 2016 | Mar. 31, 2019 | Mar. 31, 2018 | Dec. 31, 2018 | Jul. 19, 2018 | May 31, 2017 | Dec. 31, 2016 |
Long-term Debt, Gross | $ 9,610,000 | $ 9,160,000 | |||||||
Debt Instrument, Unamortized Discount, Total | 2,455,000 | 2,557,000 | |||||||
Long-term Debt, Total | 7,155,000 | ||||||||
Proceeds from Convertible Debt | 450,000 | ||||||||
Increase in Unamortized Debt Discount Due to Issuance | 63,000 | ||||||||
Amortization of Debt Discount (Premium) | 165,000 | $ 139,000 | |||||||
Interest Expense, Total | 274,000 | 237,000 | |||||||
Warrants Related to the 2017 Convertible Notes [Member] | |||||||||
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Below Investment Threshold | 10.00% | ||||||||
Percentage of Shares Issuable Upon the Conversion of the Promissory Notes | 25.00% | ||||||||
Warrants Related to the 2016 Convertible Notes [Member] | |||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.25 | ||||||||
Warrants and Rights Outstanding, Term | 10 years | ||||||||
Percentage of Shares Issuable Upon the Conversion of the Promissory Notes | 10.00% | ||||||||
Convertible Notes [Member] | |||||||||
Long-term Debt, Gross | 9,610,000 | 9,160,000 | |||||||
Debt Instrument, Unamortized Discount, Total | 2,455,000 | 2,557,000 | |||||||
Long-term Debt, Total | 7,155,000 | 6,603,000 | |||||||
Long-term Debt, Maturities, Repayments of Principal, Remainder of Fiscal Year | 0 | ||||||||
Long-term Debt, Maturities, Repayments of Principal in Year Two | 0 | ||||||||
Long-term Debt, Maturities, Repayments of Principal in Year Three | 2,990,000 | ||||||||
Long-term Debt, Maturities, Repayments of Principal in Year Four | 2,775,500 | ||||||||
Long-term Debt, Maturities, Repayments of Principal in Year Five | 3,395,000 | ||||||||
Long-term Debt, Maturities, Repayments of Principal after Year Five | 450,000 | ||||||||
Convertible Notes [Member] | Investor [Member] | |||||||||
Long-term Debt, Total | 2,252,500 | 2,252,500 | |||||||
Convertible Notes [Member] | Affiliated Entity [Member] | |||||||||
Long-term Debt, Total | 1,170,000 | 1,170,000 | |||||||
July 2018 Convertible Notes [Member] | |||||||||
Long-term Debt, Gross | 1,625,000 | 1,175,000 | |||||||
Debt Instrument, Unamortized Discount, Total | 410,000 | 360,000 | |||||||
Long-term Debt, Total | 1,215,000 | ||||||||
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement | $ 2,500,000 | ||||||||
Debt Instrument, Term | 5 years | ||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.25 | ||||||||
Proceeds from Convertible Debt | 450,000 | ||||||||
Increase in Unamortized Debt Discount Due to Issuance | 63,000 | ||||||||
Amortization of Debt Discount (Premium) | 13,000 | 0 | |||||||
Warrants Related to July 2018 Convertible Notes [Member] | |||||||||
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Below Investment Threshold | 10.00% | ||||||||
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Above Investment Threshold | 25.00% | ||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.25 | ||||||||
Warrants and Rights Outstanding, Term | 10 years | ||||||||
The 2018 Convertible Notes [Member] | |||||||||
Long-term Debt, Gross | 625,000 | 625,000 | $ 625,000 | ||||||
Debt Instrument, Unamortized Discount, Total | 220,000 | 231,000 | |||||||
Long-term Debt, Total | 405,000 | ||||||||
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement | $ 1,000,000 | ||||||||
Debt Instrument, Term | 5 years | ||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.25 | ||||||||
Proceeds from Convertible Debt | |||||||||
Increase in Unamortized Debt Discount Due to Issuance | |||||||||
Amortization of Debt Discount (Premium) | 11,000 | 0 | |||||||
Class of Warrant or Right, Outstanding | 460,000 | ||||||||
Warrants Related to the 2018 Convertible Notes [Member] | |||||||||
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Below Investment Threshold | 10.00% | ||||||||
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Above Investment Threshold | 25.00% | ||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.25 | ||||||||
Warrants and Rights Outstanding, Term | 10 years | ||||||||
The 2017 Convertible Notes [Member] | |||||||||
Long-term Debt, Gross | 4,370,000 | 4,370,000 | $ 4,420,000 | ||||||
Debt Instrument, Unamortized Discount, Total | 441,000 | 456,000 | |||||||
Long-term Debt, Total | 3,929,000 | ||||||||
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement | $ 5,000,000 | ||||||||
Debt Instrument, Term | 5 years | ||||||||
Proceeds from Convertible Debt | |||||||||
Increase in Unamortized Debt Discount Due to Issuance | |||||||||
Amortization of Debt Discount (Premium) | 15,000 | 21,000 | |||||||
Debt Instrument, Interest Rate, Stated Percentage | 6.00% | ||||||||
Interest Expense, Total | 80,000 | 74,000 | |||||||
Warrants Related to the 2017 Convertible Notes [Member] | |||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 2,307,207 | ||||||||
The 2016 Convertible Notes [Member] | |||||||||
Long-term Debt, Gross | 2,990,000 | $ 2,990,000 | |||||||
Debt Instrument, Unamortized Discount, Total | 1,384,000 | $ 1,510,000 | |||||||
Long-term Debt, Total | 1,606,000 | ||||||||
Debt Instrument, Term | 5 years | ||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.25 | ||||||||
Proceeds from Convertible Debt | |||||||||
Increase in Unamortized Debt Discount Due to Issuance | |||||||||
Amortization of Debt Discount (Premium) | 126,000 | 118,000 | |||||||
Debt Instrument, Interest Rate, Stated Percentage | 6.00% | ||||||||
Interest Expense, Total | $ 169,000 | $ 163,000 | |||||||
The 2016 Convertible Notes [Member] | Maximum [Member] | |||||||||
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement | $ 3,000,000 |
Note 4 - Senior Convertible N_4
Note 4 - Senior Convertible Notes and Warrants - Schedule of Senior Convertible Notes Outstanding (Details) - USD ($) | 3 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | |
Face value | $ 9,160,000 | |
Notes issued in current period | 450,000 | |
Face value | 9,610,000 | |
Debt discount | (2,557,000) | |
Debt discount on notes issued in current period | (63,000) | |
Amortization of discount reported as interest | 165,000 | $ 139,000 |
Debt discount | (2,455,000) | |
Senior Convertible Notes (net) | 7,155,000 | |
July 2018 Convertible Notes [Member] | ||
Face value | 1,175,000 | |
Notes issued in current period | 450,000 | |
Face value | 1,625,000 | |
Debt discount | (360,000) | |
Debt discount on notes issued in current period | (63,000) | |
Amortization of discount reported as interest | 13,000 | 0 |
Debt discount | (410,000) | |
Senior Convertible Notes (net) | 1,215,000 | |
The 2018 Convertible Notes [Member] | ||
Face value | 625,000 | |
Notes issued in current period | ||
Face value | 625,000 | |
Debt discount | (231,000) | |
Debt discount on notes issued in current period | ||
Amortization of discount reported as interest | 11,000 | 0 |
Debt discount | (220,000) | |
Senior Convertible Notes (net) | 405,000 | |
The 2017 Convertible Notes [Member] | ||
Face value | 4,370,000 | |
Notes issued in current period | ||
Face value | 4,370,000 | |
Debt discount | (456,000) | |
Debt discount on notes issued in current period | ||
Amortization of discount reported as interest | 15,000 | 21,000 |
Debt discount | (441,000) | |
Senior Convertible Notes (net) | 3,929,000 | |
The 2016 Convertible Notes [Member] | ||
Face value | 2,990,000 | |
Notes issued in current period | ||
Face value | 2,990,000 | |
Debt discount | (1,510,000) | |
Debt discount on notes issued in current period | ||
Amortization of discount reported as interest | 126,000 | $ 118,000 |
Debt discount | (1,384,000) | |
Senior Convertible Notes (net) | $ 1,606,000 |
Note 5 - Unsecured Subordinat_2
Note 5 - Unsecured Subordinated Promissory Notes (Details Textual) - USD ($) | 3 Months Ended | ||
Mar. 31, 2018 | Mar. 31, 2019 | Dec. 31, 2018 | |
Short-term Debt, Total | $ 125,000 | ||
Unsecured Subordinated Promissory Notes [Member] | |||
Short-term Debt, Total | $ 125,000 | ||
Debt Instrument, Interest Rate, Stated Percentage | 6.00% | ||
Debt Instrument, Term | 90 days |
Note 6 - Right-to-use Buildin_2
Note 6 - Right-to-use Building Asset (Details Textual) - USD ($) | 3 Months Ended | |
Mar. 31, 2019 | Jan. 01, 2019 | |
Operating Lease, Liability, Total | $ 257,000 | |
Lessee, Operating Lease, Discount Rate | 6.00% | |
Operating Lease, Cost | $ 30,000 | |
Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year | 85,000 | |
Lessee, Operating Lease, Liability, Payments, Due Year Two | 114,000 | |
Lessee, Operating Lease, Liability, Payments, Due Year Three | 57,000 | |
Lessee, Operating Lease, Liability, Payments, Due, Total | 256,000 | |
Lessee, Operating Lease, Liability, Undiscounted Excess Amount | $ 18,000 |
Note 7 - Software (Details Text
Note 7 - Software (Details Textual) - USD ($) | 3 Months Ended | ||
Mar. 31, 2019 | Mar. 31, 2018 | Dec. 31, 2018 | |
Capitalized Computer Software, Amortization | $ 4,000 | $ 31,000 | |
Capitalized Computer Software, Net, Ending Balance | 6,000 | $ 71,000 | $ 10,000 |
Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year | $ 6,000 | ||
Computer Software, Intangible Asset [Member] | |||
Finite-Lived Intangible Asset, Useful Life | 3 years |
Note 8 - Property and Equipme_3
Note 8 - Property and Equipment (Details Textual) - USD ($) | 3 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | |
Depreciation, Total | $ 7,000 | $ 13,000 |
Note 8 - Property and Equipme_4
Note 8 - Property and Equipment - Property and Equipment (Details) - USD ($) | Mar. 31, 2019 | Dec. 31, 2018 |
Office equipment | $ 249,000 | $ 249,000 |
Shop equipment | 182,000 | 182,000 |
Leasehold improvements | 253,000 | 253,000 |
684,000 | 684,000 | |
Less accumulated depreciation | (629,000) | (622,000) |
Net property and equipment | $ 55,000 | $ 62,000 |
Note 9 - Business Segments (Det
Note 9 - Business Segments (Details Textual) | 3 Months Ended |
Mar. 31, 2019 | |
Number of Operating Segments | 2 |
Note 9 - Business Segments - Op
Note 9 - Business Segments - Operation by Segments (Details) - USD ($) | 3 Months Ended | ||
Mar. 31, 2019 | Mar. 31, 2018 | Dec. 31, 2018 | |
Revenue | $ 7,000 | $ 8,000 | |
Earnings (loss) on revenue | 1,000 | (29,000) | |
Total costs and expenses | 875,000 | 1,030,000 | |
Loss from operations | 874,000 | 1,059,000 | |
Interest and other expense | 274,000 | 236,000 | |
Net loss | 1,148,000 | 1,295,000 | |
Stock based compensation | 59,000 | 2,000 | |
Depreciation and amortization | 11,000 | 44,000 | |
Assets | 355,000 | 2,157,000 | $ 150,000 |
Earnings (loss) on revenue | (1,000) | 29,000 | |
Operating Segments [Member] | CURA Division [Member] | |||
Revenue | 7,000 | 8,000 | |
Earnings (loss) on revenue | 1,000 | (29,000) | |
Total costs and expenses | 339,000 | 523,000 | |
Loss from operations | 338,000 | 552,000 | |
Interest and other expense | |||
Net loss | 338,000 | 552,000 | |
Stock based compensation | 8,000 | (16,000) | |
Depreciation and amortization | 6,000 | 37,000 | |
Assets | 9,000 | 1,860,000 | |
Earnings (loss) on revenue | (1,000) | 29,000 | |
Operating Segments [Member] | Aegis Division [Member] | |||
Revenue | |||
Earnings (loss) on revenue | |||
Total costs and expenses | 169,000 | 131,000 | |
Loss from operations | 169,000 | 131,000 | |
Interest and other expense | |||
Net loss | 169,000 | 131,000 | |
Stock based compensation | 8,000 | 2,000 | |
Depreciation and amortization | 5,000 | 5,000 | |
Assets | 50,000 | 70,000 | |
Earnings (loss) on revenue | |||
Corporate, Non-Segment [Member] | |||
Revenue | |||
Earnings (loss) on revenue | |||
Total costs and expenses | 367,000 | 376,000 | |
Loss from operations | 367,000 | 376,000 | |
Interest and other expense | 274,000 | 236,000 | |
Net loss | 641,000 | 612,000 | |
Stock based compensation | 43,000 | 16,000 | |
Depreciation and amortization | 2,000 | ||
Assets | 296,000 | 227,000 | |
Earnings (loss) on revenue |
Note 10 - Preferred and Commo_2
Note 10 - Preferred and Common Stock (Details Textual) - USD ($) | 3 Months Ended | 12 Months Ended | ||
Mar. 31, 2019 | Mar. 31, 2018 | Dec. 31, 2016 | Dec. 31, 2018 | |
Common stock, shares authorized (in shares) | 400,000,000 | 400,000,000 | ||
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | ||
Preferred stock, shares authorized (in shares) | 100,000,000 | 100,000,000 | ||
Preferred Stock, Par or Stated Value Per Share | $ 0.01 | $ 0.01 | ||
Series C3 Preferred Stock [Member] | ||||
Stock Issued During Period, Shares, Conversion of Convertible Securities | 80,000 | |||
Preferred stock, shares outstanding (in shares) | 3,268,000 | 3,268,000 | ||
Series C3 Preferred Stock [Member] | Private Placement [Member] | ||||
Stock Issued During Period, Shares, New Issues | 6,042,000 | |||
Preferred Class A [Member] | ||||
Preferred stock, shares outstanding (in shares) | 468,221 | 468,221 | ||
Preferred Stock, Shares Outstanding, Not Accruing Dividends | 8,709 | |||
Preferred Stock, Shares Outstanding, Accruing Dividends | 459,512 | |||
Dividends Payable | $ 2,576,000 | $ 2,530,000 | ||
Preferred Stock, Liquidation Preference, Value | $ 2,576,000 | $ 2,530,000 | ||
Preferred Stock, Liquidation Preference Per Share | $ 4 | |||
Preferred Class B [Member] | ||||
Preferred stock, shares outstanding (in shares) | 67,500 | 67,500 | ||
Dividends Payable | $ 462,000 | $ 454,000 | ||
Preferred Stock, Liquidation Preference, Value | $ 462,000 | $ 454,000 | ||
Preferred Stock, Liquidation Preference Per Share | $ 5 | |||
Series C Preferred Stock [Member] | ||||
Preferred stock, shares outstanding (in shares) | 15,687,500 | 15,687,500 | ||
Preferred Stock, Liquidation Preference, Value | $ 6,275,000 | $ 6,275,000 | ||
Preferred Stock, Liquidation Preference Per Share | $ 0.40 | |||
Series C2 Preferred Stock [Member] | ||||
Preferred stock, shares outstanding (in shares) | 24,500,000 | 24,500,000 | ||
Preferred Stock, Liquidation Preference, Value | $ 4,900,000 | $ 4,900,000 | ||
The 2016 and 2017 Convertible Note [Member] | ||||
Stock Issued During Period, Shares, New Issues | 35,996 | |||
Shares Issued, Price Per Share | $ 0.25 |
Note 11 - Stock Options (Detail
Note 11 - Stock Options (Details Textual) - USD ($) | 3 Months Ended | 12 Months Ended | |||
Mar. 31, 2019 | Mar. 31, 2018 | Dec. 31, 2011 | Dec. 31, 2018 | Dec. 31, 2016 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 0 | 0 | |||
Share-based Payment Arrangement, Expense | $ 59,000 | $ 2,000 | |||
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total | $ 238,000 | ||||
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition | 1 year 36 days | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | $ 0 | $ 0.33 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | $ 4,000 | $ 22,000 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | 0 | 0 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Total | 0 | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | 0 | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | 191,875 | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance | 11,028,500 | 11,028,500 | |||
Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit | $ 0.22 | ||||
Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit | $ 1.58 | ||||
Stock Option Plan 2016 [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 3,000,000 | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 1,220,000 | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | 1,780,000 | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance | 1,220,000 | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | 270,000 | ||||
Stock Option Plan 2011 [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 3,000,000 | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 0 | 150,000 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | 91,500 | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum | 10.00% | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date | 110.00% | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period | 10 years | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance | 2,908,500 | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | 2,048,500 | ||||
Stock Option Plan 2011 [Member] | Minimum [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 3 years |
Note 11 - Stock Options - Stock
Note 11 - Stock Options - Stock Options Valuation Assumptions (Details) | 3 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | |
Expected term (years) (Year) | 6 years 109 days | |
Expected forfeiture rate | 0.00% | |
Risk-free rate | 2.60% | |
Volatility | 130.00% | |
Dividend yield | 0.00% |
Note 11 - Stock Options - Share
Note 11 - Stock Options - Share-based Compensation, Stock Options, Activity (Details) - USD ($) | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | Dec. 31, 2018 | |
Outstanding shares (in shares) | 11,028,500 | ||
Outstanding - weighted average exercise price (in dollars per share) | $ 0.49 | ||
Outstanding - weighted average remaining contractual term (Year) | 3 years 182 days | 3 years 292 days | |
Outstanding - aggregate intrinsic value | $ 94,000 | ||
Shares, granted (in shares) | 0 | 0 | |
Weighted average exercise price, granted (in dollars per share) | |||
Shares, exercised (in shares) | 0 | 0 | |
Weighted average exercise price, exercised (in dollars per share) | |||
Shares, canceled or expired (in shares) | 0 | ||
Weighted average exercise price, canceled or expired (in dollars per share) | |||
Outstanding shares (in shares) | 11,028,500 | 11,028,500 | |
outstanding - weighted average exercise price (in dollars per share) | $ 0.49 | $ 0.49 | |
Shares, exercisable (in shares) | 7,068,500 | ||
Weighted average exercise price, exercisable (in dollars per share) | $ 0.58 | ||
Exercisable- weighted average remaining contractual term (Year) | 2 years 255 days | ||
Exercisable-aggregate intrinsic value |
Note 12 - Warrants (Details Tex
Note 12 - Warrants (Details Textual) - shares | Mar. 31, 2019 | Dec. 31, 2018 |
Warrants without Expiration Date, Outstanding | 743,500 | 743,500 |
Warrants without Expiration Date, Exercisable | 118,500 | 118,500 |
Warrants Not Determined, Exercise Price [Member] | ||
Class of Warrant or Right, Outstanding | 1,750,000 | 1,750,000 |
Note 12 - Warrants - Summary of
Note 12 - Warrants - Summary of Outstanding Warrants (Details) - USD ($) | 3 Months Ended | 12 Months Ended | ||
Mar. 31, 2019 | Mar. 31, 2018 | Dec. 31, 2018 | ||
Outstanding shares (in shares) | 11,028,500 | |||
Outstanding - weighted average exercise price (in dollars per share) | $ 0.49 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 0 | 0 | ||
Weighted average exercise price, granted (in dollars per share) | ||||
Shares, exercised (in shares) | 0 | 0 | ||
Weighted average exercise price, exercised (in dollars per share) | ||||
Shares, canceled or expired (in shares) | 0 | |||
Weighted average exercise price, canceled or expired (in dollars per share) | ||||
Outstanding shares (in shares) | 11,028,500 | 11,028,500 | ||
outstanding - weighted average exercise price (in dollars per share) | $ 0.49 | $ 0.49 | ||
Shares, exercisable (in shares) | 7,068,500 | |||
Weighted average exercise price, exercisable (in dollars per share) | $ 0.58 | |||
Exercisable - weighted average remaining contractual term (Year) | 2 years 255 days | |||
Exercisable - aggregate intrinsic value | ||||
Warrant [Member] | ||||
Outstanding shares (in shares) | 7,381,707 | |||
Outstanding - weighted average exercise price (in dollars per share) | [1] | $ 0.46 | ||
Outstanding - weighted average remaining contractual term (Year) | [2] | 6 years 328 days | 7 years | |
Outstanding - aggregate intrinsic value | $ 31,000 | $ 39,000 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 330,000 | |||
Weighted average exercise price, granted (in dollars per share) | $ 0.25 | |||
Shares, exercised (in shares) | ||||
Weighted average exercise price, exercised (in dollars per share) | ||||
Shares, canceled or expired (in shares) | ||||
Weighted average exercise price, canceled or expired (in dollars per share) | ||||
Outstanding shares (in shares) | 7,711,707 | 7,381,707 | ||
outstanding - weighted average exercise price (in dollars per share) | [1] | $ 0.45 | $ 0.46 | |
Shares, exercisable (in shares) | 7,070,786 | |||
Weighted average exercise price, exercisable (in dollars per share) | $ 0.44 | |||
Exercisable - weighted average remaining contractual term (Year) | [3] | 7 years | ||
Exercisable - aggregate intrinsic value | $ 30,000 | |||
[1] | The weighted average exercise price for warrants outstanding as of March 31, 2019 and 2018 excludes 1,750,000 warrants in each period with no determined exercise price. | |||
[2] | The weighted average remaining contractual term for warrants outstanding as of March 31, 2019 and 2018 excludes 743,500 warrants with no expiration date. | |||
[3] | The weighted average remaining contractual term for warrants exercisable as of March 31, 2019, and 2018 excludes 118,500 warrants with no expiration date. |
Note 13 - Related Party Trans_2
Note 13 - Related Party Transactions (Details Textual) | May 08, 2018 | Mar. 31, 2019USD ($)shares | Mar. 31, 2018USD ($) | Dec. 31, 2018USD ($)shares |
Proceeds from Short-term Debt, Total | $ 125,000 | |||
The 2018 Convertible Notes [Member] | ||||
Debt Instrument, Term | 5 years | |||
Six Members of the Board of Directors [Member] | Warrants Related to the 2018 Convertible Notes [Member] | ||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 1,239,285 | 1,239,285 | ||
Six Members of the Board of Directors [Member] | The 2018 Convertible Notes [Member] | ||||
Debt Instrument, Face Amount | $ 2,252,500 | $ 2,252,500 | ||
Debt Instrument, Convertible, Number of Equity Instruments | 7,888,378 | 7,888,378 | ||
Chief Executive Officer [Member] | Unsecured Subordinated Promissory Notes [Member] | ||||
Proceeds from Short-term Debt, Total | $ 125,000 | |||
Debt Instrument, Term | 90 days | |||
Debt Instrument, Interest Rate, Stated Percentage | 6.00% |
Note 14 - Subsequent Events (De
Note 14 - Subsequent Events (Details Textual) - USD ($) | 1 Months Ended | 3 Months Ended | ||
May 14, 2019 | Mar. 31, 2019 | Apr. 04, 2019 | Dec. 31, 2018 | |
Short-term Debt, Total | $ 125,000 | |||
Stock Issued During Period, Value, Interest | $ 8,000 | |||
Unsecured Subordinated Promissory Notes [Member] | Chief Executive Officer [Member] | ||||
Debt Instrument, Interest Rate, Stated Percentage | 6.00% | |||
Subsequent Event [Member] | ||||
Stock Issued During Period, Shares, Interest | 34,356 | |||
Stock Issued During Period, Value, Interest | $ 8,589 | |||
Subsequent Event [Member] | Warrants Related to July 2018 Convertible Notes [Member] | ||||
Class Of Warrant Or Right Issued In Period | 20,000 | |||
Subsequent Event [Member] | July 2018 Convertible Notes [Member] | ||||
Debt Instrument, Face Amount | $ 50,000 | |||
Subsequent Event [Member] | Unsecured Subordinated Promissory Notes [Member] | Chief Executive Officer [Member] | ||||
Short-term Debt, Total | $ 100,000 | |||
Debt Instrument, Interest Rate, Stated Percentage | 6.00% |